Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity

  • Oncotarget. 2024 Jul 17:15:501-503. doi: 10.18632/oncotarget.28610.
Jack G Fisher ,  Lara V Graham ,  Matthew D Blunt
PMID: 39018202 DOI: 10.18632/oncotarget.28610
Keywords
HLA-E; NKG2A; Natural killer (NK) cells; immune checkpoint blockade; immunotherapy.
Products